本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

310.47
+1.480.48%
盤前311.100.6300+0.20%04:18 EDT
成交量:55.60萬
成交額:1.73億
市值:86.47億
市盈率:-24.14
高:318.00
開:313.65
低:306.50
收:308.99
52周最高:392.70
52周最低:41.78
股本:2,785.08萬
流通股本:2,407.65萬
量比:1.83
換手率:2.31%
股息:- -
股息率:- -
每股收益(TTM):-12.8634
每股收益(LYR):-13.4758
淨資產收益率:-38.86%
總資產收益率:-25.65%
市淨率:6.45
市盈率(LYR):-23.04

資料載入中...

2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/01

重要事件披露

8-K - Current report
2020/11/23

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/17

重要事件披露

8-K - Current report
2020/11/10

重要事件披露

8-K - Current report
2020/10/20

重要事件披露

8-K - Current report
2020/10/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/15

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933